The effect of vitamin D provision on biomarkers of inflammation in bronchial asthma in children

   Introduction. Asthma is a widespread disease in childhood and has a persistent tendency to increase. Therefore, the search for factors influencing this process, as well as biomarkers reflecting the degree of asthma control, is an urgent problem.

   Objective. To study the relationship of vitamin D levels with the serum periostin and TGF-β1 concentration in children with asthma.

   Materials and methods. The cross-sectional (one-stage) study included 80 children aged 6 to 17 years (average age — 12 ± 3.2 g). The subjects were divided into 2 groups: children with asthma — group 1 (n = 40); group 2 — the control group (n = 40). In all children, the assessment of the concentration of 25(OH)D, periostin and TGF-β1 in the blood serum was studied.

   Results. Median (Me) 25(OH) in patients with asthma was statistically significantly lower than in children of the comparison group (16.7 ng/ml, versus 25.7 ng/ml, p = 0.017), and did not depend on the severity of the disease, corresponded to a deficiency condition in both mild (16.2 ng/ml) and with an average severity of asthma (16.8 ng/ml) (p = 0.041). Me of periostin in 1st group was within the normal range (730.2 ng/ml), but statistically significantly exceeded the indicator of 2nd group (539.7 ng/ml, p < 0.05) and did not depend on the age and duration of asthma. High rates of periostin were observed in children with moderate severity of asthma with a disease experience of 4–6 years (617.2 ng/ml). Me of TGF-β1 in both groups corresponded to normal values (309.0 and 369.6 pg/ml, respectively, p > 0.05) and did not depend on the age and duration of asthma.

   Conclusions. VD deficiency is registered in children with asthma 2 times more often than in healthy children in Ryazan region. The serum concentration of periostin increased in proportion to the severity of asthma. Vitamin D deficiency can be one of the risk factors for the development of asthma and lead to an imbalance in the periostin and TGF-β system.

1. Bronchial asthma: federal clinical guidelines for diagnosis and treatment. 2021. 118 p. (In Russ.)

2. Belykh NA, Pisnyur IV. Modern ideas about the role of vitamin D in the pathogenesis of bronchial asthma in children. The Science of the Young (Eruditio Juvenium). 2020; 8 (4): 617–628. (In Russ.)] URL: https://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-roli-vitamina-d-v-patogeneze-bronhialnoy-astmy-u-detey

3. Tribuntseva LV, Avdeev SN, Budnevsky AV, Prozorova GG, Kozhevnikova SA. The combined effect of multimorbidity and an increased body mass index on the control of bronchial asthma and the quality of life of patients. academician I. P. Pavlov. 2023; 31 (1): 37–48. doi: 10.17816/PAVLOVJ111895. (In Russ.)

4. Salmanpour F, Kian N, Samieefar N, et al. Asthma and Vitamin D Deficiency: Occurrence, Immune Mechanisms, and New Perspectives. IJ Immunol Res. 2022; 2022: 1–7. doi: 10.1155/2022/6735900.

5. Izuhara K, Nunomura S, Nanri Y, et al. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019; 74 (11): 2116–2128. doi: 10.1111/all.13814.

6. Novosad J, Krčmová I, Bartoš V, et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020; 37 (2): 240–249. doi: 10.5114/ada.2020.94842.

7. Yu L, Wang J, Liu K. Role of periostin in ECRS. Eur Arch Otorhinolaryngol. 2021; 278 (8): 2665–2672. doi: 10.1007/s00405-020-06369-x.

8. Turczyn A, Pańczyk-Tomaszewska M. The role of periostin in kidney diseases. Cent Eur J Immunol. 2021; 46 (4): 494–501. doi: 10.5114/ceji.2021.110317.

9. Alzobaidi N, Rehman S, Naqvi M, Gulati K, Ray A. Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases. J Pharm Pharm Sci. 2022; 25: 137–148. doi: 10.18433/jpps32306.

10. Potapova NL, Gaimolenko IN. Analysis of the level of transforming growth factor Β1 in children with bronchial asthma. Mother and child in Kuzbass. 2019; 4 (79): 21–25. (In Russ.)

11. Rozmus D, Ciesielska A, Płomiński J, et al. Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases. Int J Mol Sci. 2020; 21 (21): 7822 doi: 10.3390/ijms21217822.

12. Li Q, Zhou Q, Zhang G. et al. Vitamin D Supplementation and Allergic Diseases during Childhood: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14 (19): 3947. doi: 10.3390/nu14193947.

13. Williamson A, Martineau AR, Sheikh A, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2023; 6 (2): CD011511. doi: 10.1002/14651858.CD011511.pub3.

14. Esfandiar N, Alaei F, Fallah S, et al. Vitamin D deficiency and its impact on asthma severity in asthmatic children. Ital J Pediatr. 2016; 42 (1): 108. doi: 10.1186/s13052-016-0300-5.

15. Costa Dias Ladeira JM, Zacas O, Ferreira AM. et al. The role of vitamin D in the severity and control of asthma in children and adolescents: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101 (50): e31457. doi: 10.1097/MD.0000000000031457.

16. Global Strategy for Asthma Management and Prevention. Updated 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf

17. Borovik TE, Gromova OA, Zakharova VV, Maltsev SV, Moshetova LK, Namazova-Baranova LS, etc. Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction. The national program. Moscow. Publishing house «Pediatrician», 2021. 116 p. (In Russ.)

18. Kalashnikova LA, Danilova MS, Shabalina AA et al. Transforming growth factor beta in patients with dissection of internal carotid and vertebral arteries. Journal of Neurology and Psychiatry named after S. S. Korsakov. 2022; 122 (10): 82–87. doi: 10.17116/jnevro202212210182. (In Russ.)

19. Wang Q, Ying Q, Zhu W, et al. Vitamin D and asthma occurrence in children : A systematic review and meta-analysis. J Pediatr Nurs. 2022; e60–e68. doi: 10.1016/j.pedn.2021.07.005.

20. Masalskiy SS, Kalmykova AS, Ukhanova OP. Features of vitamin D provision in various clinical course of bronchial asthma in children and adolescents. Allergology and immunology in pediatrics. 2018; 1 (52): 25–32. (In Russ.)

21. Inoue T, Akashi K, Watanabe M, et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016; 27 (5): 521–526. doi: 10.1111/pai.12575.

22. Song JS, You JS, Jeong SI, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70 (6): 674–681. doi: 10.1111/all.12599.

23. Yavuz ST, Bagci S, Bolat A, et al. Association of serum periostin levels with clinical features in children with asthma. Pediatr Allergy Immunol. 2021; 32 (5): 937–944. doi: 10.1111/pai.13444.

24. Masalskiy SS, Kalmykova AS, Ukhanova OP. Сomplex evaluation of serum periostin — new marker of allergic inflammation at uncontrolled bronchial asthma at children. Russian Journal of Allergy. 2018; 15 (1S): 55–57. URL: https://elibrary.ru/item.asp?id=36409805. (In Russ.)